Hetero-bivalent Nanobodies Provide Broad-spectrum Protection against SARS-CoV-2 Variants of Concern including Omicron
Huan Ma(University of Science and Technology of China), Tengchuan Jin(Anhui Medical University), Xiaowen Hu(Lanzhou University), Yan Wu(Chinese Academy of Sciences), Shaohong Chen(National Institute for Parasitic Diseases), Sandra Chiu(University of Science and Technology of China), Peiyi Zheng(University of Science and Technology of China), Weihong Zeng(Hefei University of Technology), Yan Xiang(Sichuan University), Peter H. Dube(Boehringer Ingelheim (United States)), Huajun Zhang(Chinese Academy of Sciences), Xinghai Zhang(Chinese Academy of Sciences), Yunru Yang(University of Science and Technology of China), Junhui Zhou(Jiangsu University)
Cited by 1
Related Papers
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
|Science Advances|2020|400
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
|Proceedings of the National Academy of Sciences|2013|342
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
|Frontiers in Chemistry|2021|311
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
|Cell Research|2020|251